Scholarly Resources

24 Hour Helpline
GET HELP NOW

Our team is constantly working with other thought leaders in the industry to publish new and exciting articles focused on advancing addiction treatment and improving client outcomes. Check out some of the most recent articles and research studies our team has been a part of below:

Studies related to "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS)

Taylor and Francis Online

The benefits of customized DNA directed nutrition to balance the brain reward circuitry

THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS
National Center for Biotechnology Information

Dopamine for Dinner: Combating clinically Reward Deficiency Syndrome.

Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner
National Center for Biotechnology Information

Hypothesizing that a pro-dopaminergic regulator can induce "Dopamine Homeostasis" and provide adjunctive detoxification benefits.

Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence ClinMed International Library

Hypothesizing reduced reward deficiency symptomatology by regulating dopamine transmission

Lyme and dopaminergic function: Hypothesizing reduced reward deficiency symptomatology by regulating dopamine transmission
Open Access Text

Molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).

Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS)
National Center for Biotechnology Information

Should we promote dopamine homeostasis to treat opiate/ opioid abuse?

Invited Commentary: In a Genomic Era, Should We Promote Dopamine Homeostasis to Treat Opiate/ Opioid Abuse, Instead of Blocking Brain Dopamine Function?
KEI Journals

Pro-dopamine regulation as a long-term therapeutic modality to overcome reduced resting state dopamine tone

Pro-Dopamine Regulation (KB220Z™)” as a Long-Term Therapeutic Modality to Overcome Reduced Resting State Dopamine Tone in Opiate /Opioid Epidemic in America
Open Access Text

Studies involving KB220Z, a pro-dopamine regulator that can induce "Homeostasis".

KB220Z a Pro-Dopamine Regulator, Balances Brain Reward Circuitry Inducing “Homeostasis.”
The Sober World

Coupling Genetic Addiction Risk Score and Pro Dopamine Regulation to Combat Substance Use Disorder.

Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)
Juniper Publishers

Should homeostatis treatment be used to treat drug abuse?

Invited Commentary: In a Genomic Era, Should We Promote Dopamine Homeostasis to Treat Opiate/ Opioid Abuse, Instead of Blocking Brain Dopamine Function?
KEI Journals

21st Century Perspective on Depression and Reward Genes

A 21ST CENTURY PERSPECTIVE ON DEPRESSION, REWARD GENES, AND DNA POLYMORPHIC TARGETED NUTRIGENOMIC RESOLUTION

International Journal of Current Research

Pro-Dopamine Regulato(KB220) to Balance Brain Reward Circuit in those Suffering from Addiction

Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).

National Institute of Health

Native Americans and the Opioid Epidemic

Genetic farming of the Opiate/Opioid epidemic in Native Americans: Is Reward Deficiency the Culprit?

Austin Psychiatry 

Mortality Risk During and After Opioid Substitution Treatment

Mortality Risk During and After Opioid Substitution Treatment: Systematic Review and Meta-Analysis of Cohort Studies

The BMJ

Pro-Dopamine Regulation (KB220Z) as a Long-Term Therapeutic Modality

“Pro-dopamine regulation (KB220Z™)” as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America.

National Institute of Health 

↓ Full text Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS)

We are faced with a worldwide opiate/opioid epidemic that is devastating. According to the Centers for Disease Control and Prevention (CDC), at least 127 people, young and old, are dying every day in America due to narcotic overdose.

National Institute of Health

The Food and Drug Addiction Epidemic:

The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis.

National Institute of Health 

Our Accreditations, Certifications & Partnerships

  • Joint Commission
  • FARR
  • Rockers in Recovery
  • My FL Families
  • Best Place to Work
  • Addict's Mom
  • PAARI
  • Rehab Reviews

Don’t Wait!
Contact the Shores Treatment & Recovery
And get the addiction help you deserve

  • This field is for validation purposes and should be left unchanged.